RIL
ANRO icon

Rothschild Investment LLC’s Alto Neuroscience ANRO Stock Holding History

Rothschild Investment LLC’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1K Sell
685
-1,000
-59% -$23.1K ﹤0.01% 1586
2026
Q1 		$37.9K Sell
1,685
-1,200
-42% -$22.2K ﹤0.01% 1205
2025
Q4 		$51.4K Hold
2,885
– – ﹤0.01% 1010
2025
Q3 		$11.6K Hold
2,885
– – ﹤0.01% 1388
2025
Q2 		$6.35K Hold
2,885
– – ﹤0.01% 1388
2025
Q1 		$6.23K Hold
2,885
– – ﹤0.01% 1339
2024
Q4 		$12.2K Hold
2,885
– – ﹤0.01% 1117
2024
Q3 		$33K Buy
+2,885
New +$35.3K ﹤0.01% 877

Other funds holding ANRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
RWM
Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return
SCM
SCS Capital Management Boston, Massachusetts $10.6B AUM 19.73% 1-Year Est. Return

Rothschild Investment LLC's ANRO Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Alto Neuroscience (ANRO) stake by 59% in Q2 2026, selling an estimated $23.1K and leaving 685 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1586.

Rothschild Investment LLC first reported a position in ANRO in Q3 2024 and has held it in 8 quarters since. The position peaked at $51.4K in Q4 2025. 26 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Rothschild Investment LLC held 685 shares of Alto Neuroscience worth $18.1K as of Q2 2026.
  • Rothschild Investment LLC sold 1,000 Alto Neuroscience shares in Q2 2026, an estimated $23.1K.
  • Alto Neuroscience made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1586 holding.
  • Rothschild Investment LLC first reported a position in Alto Neuroscience in Q3 2024 and has held it in 8 quarters since.
  • Rothschild Investment LLC's Alto Neuroscience position peaked at $51.4K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.